2017 American Transplant Congress
Live Donor (LDTx) HIV(+) Kidney Transplantation Improves Allograft Survival vs. Deceased Donor (CRD) Transplantation.
Drexel University College of Medicine, Philadelphia
Hahnemann University Hospital has performed 113 kidney transplants in HIV(+) recipients. We sought to analyze the impact of HIV(+) LDTx on allograft survival.Methods: The HIV(+)…2017 American Transplant Congress
Assessment of the Risk Index for Living Donor Kidney Transplantation (LKDPI) in a European Cohort.
Nephrology, Charité Universitaetsmedizin, Berlin, Germany
Introduction: Recently, a risk index for living donor kidney transplantation (LKDPI) was proposed (Massie et al. AJT 2016) to compare living donor kidneys (LDK) to…2017 American Transplant Congress
Meta-Analysis of Clinical Significance of Complement Activating Anti-HLA DSA in Kidney Transplantation.
Donor-specific anti-HLA antibodies (DSA) are currently recognized as the major limitation to access transplantation and the first cause of late transplant failures. The effect of…2017 American Transplant Congress
ABO-Incompatibility Using Ritiuximab Does Not Increase Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Background and aims: ABO-incompatible (ABO-I) living donor liver transplantation (LDLT) has a high success rate. However, a difference in hepatocellular carcinoma (HCC) recurrence rates has…2017 American Transplant Congress
Analysis of Outcomes in High Risk Kidney Transplants.
Kidney and Pancreas Transplantation, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY
Background: The new kidney allocation system implemented in 12/2014 utilizes estimated post-transplant survival scores (EPTS) and kidney donor profile index (KDPI) to optimize recipient survival…2017 American Transplant Congress
Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate Risk Renal Transplants: A Single Center Experience.
1Infectious Diseases, Yale University, New Haven, CT; 2Pharmacy, YNHH, New Haven, CT
IntroductionCurrent guidelines on cytomegalovirus (CMV) prophylaxis following organ transplant recommend using valganciclovir (VGCV) 900 mg daily for high (CMV D+/R-) and intermediate (CMV R+) risk…2017 American Transplant Congress
Risk Analysis of Patients with Proven Coronary Artery Disease Undergoing Liver Transplant.
Houston Methodist Hospital, Houston, TX
ObjectivesCoronary artery disease is increasing common in liver transplant (LT) candidates due to the aging population. We sought to longitudinally evaluate of outcomes of LT…2017 American Transplant Congress
Long-Term Follow-Up of the Safety and Effects of Bariatric Surgery on Immunosuppression in Post-Transplant Patients.
Objectives: To report the safety and feasibility of maintaining immunosuppression and graft safety after bariatric surgery among solid organ transplanted patients.Summary Background Data: Transplanted patients…2017 American Transplant Congress
A Comparative Study of Patient and Graft Qualities Between Abo-Compatible and -Incompatible Recipients More Than Ten Years After Kidney Transplantation.
Urology, Tokyo Women's Medical University, Tokyo, Japan
Background. The long-term benefits of ABO-I kidney transplantation in terms of adverse events due to severe immunosuppression immediately before transplantation remain unclear.Patients and Methods. Between…2017 American Transplant Congress
Induced Pluripotent Stem Cell (iPS) Derived Schwann Cells to Enhance Functional Recovery Following Nerve Injury and Limb Allotransplantation.
Background Stem cell therapies have provided new aspects for functional recovery. A novel cell-based approach utilizing human induced Pluripotent Stem Cell-derived Schwann Cells (iPSC-SCs) supported…
- « Previous Page
- 1
- …
- 114
- 115
- 116
- 117
- 118
- …
- 155
- Next Page »